OverviewSuggest Edit

QIAGEN is a company that develops Sample to Insight solutions for molecular testing. It offers sample and assay kits, instruments, automation systems, and bioinformatics solutions for analysis and interpretation. The company serves the molecular diagnostics and life sciences markets.

TypePublic
Founded1984
HQVenlo, NL
Websiteqiagen.com
Employee Ratings3.9
Overall CultureA+

Latest Updates

Employees (est.) (Dec 2020)5,610(+11%)
Job Openings226
Share Price (Nov 2021)€46.5
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Qiagen

Thierry Bernard

Thierry Bernard

Chief Executive Officer and Managing Director
Stephany Foster

Stephany Foster

Senior Vice President, Head of Human Resources
Jonathan Sheldon

Jonathan Sheldon

Senior Vice President, QIAGEN Digital Insights Business Area
Phoebe Loh

Phoebe Loh

Senior Director Investor Relations
Roland Sackers

Roland Sackers

Chief Financial Officer and Managing Director
Barthold Piening

Barthold Piening

Senior Vice President, Head of Global Operations
Show more

Qiagen Office Locations

Qiagen has offices in Venlo, Beverly, Germantown, Redwood City and in 28 other locations
Venlo, NL (HQ)
Hulsterweg 82
Chadstone, AU
1341 Dandenong Rd
Toronto, CA
4400-181 Bay St
Shanghai, CN
Blk. 20, 88 Da Er Wen Road, Zhangjiang Hi-Tech Park, Pudong
Shenzhen, CN
6&7F, R3-B, High-tech Industrial Park, NashanDistict
Aarhus, DK
Silkeborgvej 2
Show all (37)

Qiagen Financials and Metrics

Qiagen Revenue

Market capitalization (10-Nov-2021)

10.6b

Closing stock price (10-Nov-2021)

46.5
Qiagen's current market capitalization is €10.6 b.
Show all financial metrics

Qiagen Cybersecurity Score

Cybersecurity ratingPremium dataset

C

71/100

SecurityScorecard logo

Qiagen Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Qiagen Online and Social Media Presence

Embed Graph

Qiagen Company Culture

  • Overall Culture

    A+

    88/100

  • CEO Rating

    A+

    86/100

  • Compensation

    A-

    80/100

Learn more on Comparably

Qiagen News and Updates

Global Tissue Diagnostics Technology and Market Research Report 2021-2026 Featuring Abbott Diagnostics, Becton, Dickinson and Co., General Electric, Merck, Qiagen. and Thermo Fisher Scientific

DUBLIN, Oct. 22, 2021 /PRNewswire/ -- The "Tissue Diagnostics: Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global tissue diagnostics market should reach $6.4 billion by 2026 from $4.7 billion in 2021 at a compound annual...

Global Liquid Biopsy Market Report 2021-2028 Featuring Qiagen, F. Hoffmann-La Roche, Bio-Rad Laboratories, Illumina, Inivata, Agena Bioscience, Thermo Fisher Scientific, Guardant Health

DUBLIN, Sept. 24, 2021 /PRNewswire/ -- The "Global Liquid Biopsy Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The global liquid biopsy market attained revenue of close to USD 3160 Million in 2019 and is estimated to garner over USD 25800 Million in 2028....

Covid Test Maker Qiagen Wants to Know Staff’s Vaccine Status

Covid Test Maker Qiagen Wants to Know Staff’s Vaccine Status

Qiagen stock reverses lower after upbeat Q2 outlook, but downbeat Q3 view

Shares of Qiagen N.V. slumped 4.5% in morning trading Monday, reversing an earlier intraday gain of as much 1.7%, after the Netherlands-based biotechnology company provided an upbeat second-quarter revenue outlook, citing stronger-than-expected sales of non-COVID product groups, but also a downbeat…

Insights on the Liquid Biopsy Global Market to 2028 - Featuring Qiagen NV, Biocept and Illumina Among Others

Dublin, May 26, 2021 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market by Clinical Application, Therapeutic Application, Biomarker Type, Analysis Platform, Analysis Purpose, Product, Industry Verticals, and Geography - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering…

Worldwide Cervical Dysplasia Industry to 2028 - Players Include Qiagen, Abbott Laboratories and Hologic Among Others

DUBLIN, May 11, 2021 /PRNewswire/ -- The "Cervical Dysplasia Market Share, Size, Trends, Industry Analysis Report, By Type; By End-Use, By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering. The global cervical dysplasia market size is...
Show more

Qiagen Blogs

Protein coding gene prediction using QIAGEN CLC Genomics Workbench

Ab initio gene finding is a central step in genome analysis, which must account for the biology of the investigated... The post Protein coding gene prediction using QIAGEN CLC Genomics Workbench appeared first on Bioinformatics Software and Services | QIAGEN Digital Insights.

GeneMark-ES Gene Finding (commercial plugin)

GeneMark-ES Gene Finding The GeneMark-ES Gene Finding plugin offers an innovative approach to finding genes in eukaryotic genomes along with... The post GeneMark-ES Gene Finding (commercial plugin) appeared first on Bioinformatics Software and Services | QIAGEN Digital Insights.

Demonstrating Ingenuity Pathway Analysis (IPA) on CAR-Ts and T-Cell Exhaustion – Dec. 9

Join us for a 60-minute Webinar on Systems Analysis of Cell Therapies: Demonstrating Ingenuity Pathway (IPA) on CAR-Ts and T-Cell... The post Demonstrating Ingenuity Pathway Analysis (IPA) on CAR-Ts and T-Cell Exhaustion – Dec. 9 appeared first on Bioinformatics Software and Services | QIAGEN Digita…

Download Pathogen Database returns too few reference sequences

Download Pathogen Database returns too few reference sequences Issue description Multiple issues have been identified with the Download Pathogen Database... The post Download Pathogen Database returns too few reference sequences appeared first on Bioinformatics Software and Services | QIAGEN Digital…

Human Somatic Mutation Database (HSMD)

The post Human Somatic Mutation Database (HSMD) appeared first on Bioinformatics Software and Services | QIAGEN Digital Insights.

Transmembrane Helix Prediction always reports no transmembrane regions found

Transmembrane Helix Prediction always reports no transmembrane regions found Issue description Since October 22, 2021, the Transmembrane Helix Prediction tool... The post Transmembrane Helix Prediction always reports no transmembrane regions found appeared first on Bioinformatics Software and Servic…
Show more

Qiagen Frequently Asked Questions

  • When was Qiagen founded?

    Qiagen was founded in 1984.

  • Who are Qiagen key executives?

    Qiagen's key executives are Thierry Bernard, Stephany Foster and Jonathan Sheldon.

  • How many employees does Qiagen have?

    Qiagen has 5,610 employees.

  • Who are Qiagen competitors?

    Competitors of Qiagen include bioMerieux, VWR and Hologic.

  • Where is Qiagen headquarters?

    Qiagen headquarters is located at Hulsterweg 82, Venlo.

  • Where are Qiagen offices?

    Qiagen has offices in Venlo, Beverly, Germantown, Redwood City and in 28 other locations.

  • How many offices does Qiagen have?

    Qiagen has 37 offices.